Mehta Vimal
CEO and President at BTAI
- Sold, on record
- $18.5M
- Dollars the filings state
- Form 4 sales
- 10
- Latest May 20, 2026
- Form 144 notices
- 6
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BTAIBioXcel Therapeutics, Inc.CEO and President
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BTAIRoutineApr 4, 2024 2024
Sold 5,268 shares at $2.62 ($14k)
Mehta Vimal, CEO and President
10b5-1 planSold 10.8% of holdings ($128k position)43,564 shares left0.1x usual sizeFollows a Form 144Filing
- 2 Form 144 notice BTAINoticeJun 17, 2024 +74 days
Filed to sell 2,134 shares ($3k)
Mehta Vimal, Officer
10b5-1 plan0x usual sizeFiling
- 3 Form 4 sale BTAIRoutineJun 17, 2024 same day
Sold 2,134 shares at $1.28 ($3k)
Mehta Vimal, CEO and President
10b5-1 planSold 4.3% of holdings ($64k position)47,539 shares left0x usual sizeFollows a Form 144Filing
- 4 Form 144 notice BTAINoticeSep 16, 2024 +91 days
Filed to sell 1,982 shares ($1k)
Mehta Vimal, Officer
10b5-1 plan0.1x usual sizeFiling
- 5 Form 4 sale BTAIRoutineSep 16, 2024 same day
Sold 1,982 shares at $0.69 ($1k)
Mehta Vimal, CEO and President
10b5-1 planSold 3.7% of holdings ($37k position)51,666 shares left0.1x usual sizeFollows a Form 144Filing
- 6 Form 144 notice BTAINoticeDec 16, 2024 +91 days
Filed to sell 2,298 shares ($793)
Mehta Vimal, Officer
10b5-1 planFirst sale on recordFiling
- 7 Form 4 sale BTAIRoutineDec 16, 2024 same day
Sold 3,117 shares at $0.36 ($1k)
Mehta Vimal, CEO and President
10b5-1 planSold 5% of holdings ($23k position)59,605 shares leftFirst sale on recordFollows a Form 144Filing
- 8 Form 4 sale BTAIUnusualMay 20, 2026 +520 days
Sold 19,419 shares at $1.09 ($21k)
Mehta Vimal, CEO and President
10b5-1 planSold 21.8% of holdings ($97k position)69,598 shares left9.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (16)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 20, 2026 | May 22, 2026 | BTAI | CEO and President | Form 4 sale | 19,419 | $21k | 21.8% | Unusual | SEC |
| Dec 16, 2024 | Dec 17, 2024 | BTAI | CEO and President | Form 4 sale | 3,117 | $1k | 5.0% | Routine | SEC |
| Dec 16, 2024 | Dec 16, 2024 | BTAI | Officer | Form 144 notice | 2,298 | $793 | Notice | SEC | |
| Sep 16, 2024 | Sep 17, 2024 | BTAI | CEO and President | Form 4 sale | 1,982 | $1k | 3.7% | Routine | SEC |
| Sep 16, 2024 | Sep 16, 2024 | BTAI | Officer | Form 144 notice | 1,982 | $1k | Notice | SEC | |
| Jun 17, 2024 | Jun 18, 2024 | BTAI | CEO and President | Form 4 sale | 2,134 | $3k | 4.3% | Routine | SEC |
| Jun 17, 2024 | Jun 17, 2024 | BTAI | Officer | Form 144 notice | 2,134 | $3k | Notice | SEC | |
| Apr 4, 2024 | Apr 8, 2024 | BTAI | CEO and President | Form 4 sale | 5,268 | $14k | 10.8% | Routine | SEC |
| Apr 4, 2024 | Apr 4, 2024 | BTAI | Officer | Form 144 notice | 5,268 | $14k | Notice | SEC | |
| Jun 16, 2023 | Jun 16, 2023 | BTAI | CEO and President | Form 4 sale | 60,000 | $1.3M | 60.1% | Routine | SEC |
| Jun 15, 2023 | Jun 15, 2023 | BTAI | Officer | Form 144 notice | 60,000 | $900k | Notice | SEC | |
| May 22, 2023 | May 24, 2023 | BTAI | CEO and President | Form 4 sale | 6,500 | $168k | 14.8% | Routine | SEC |
| May 22, 2023 | May 22, 2023 | BTAI | Officer | Form 144 notice | 6,500 | $168k | Notice | SEC | |
| Mar 21, 2023 | Mar 22, 2023 | BTAI | CEO and President | Form 4 sale | 64,500 | $1.2M | 80.2% | Unusual | SEC |
| Dec 16, 2022 | Dec 19, 2022 | BTAI | CEO and President | Form 4 sale | 60,000 | $1.2M | 85.8% | Unusual | SEC |
| Jun 25, 2021 | Jun 29, 2021 | BTAI | CEO, President and Secretary | Form 4 sale | 473,250 | $14.6M | 5.2% | Plan not stated | SEC |